Infant Protection Against Respiratory Syncytial Virus (RSV) by Maternal RSV Vaccination or Receipt of Nirsevimab, and Intent for Nirsevimab Receipt, United States

ICPSR Data Holdings 2026 Dataset Open access

Read full text
Authors: United States Department of Health and Human Services. Centers for Disease Control and Prevention, Pregnancy & Vaccination
DOI: 10.3886/e242834v1
Cited by: 0

Abstract

Infant Protection Against RSV by Maternal RSV Vaccination or Receipt of Nirsevimab and Intent for Nirsevimab Receipt, Reported by Females Aged 18-49 Years Who Have an Infant

Publication details

Journal / source
ICPSR Data Holdings
Publication date
1 January 2026
Language
EN
Document type
Dataset